日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Machine learning-based prediction of tubulointerstitial lesions in diabetic kidney disease: a multicenter validation study

基于机器学习的糖尿病肾病肾小管间质病变预测:一项多中心验证研究

Xu, Chengren; Shen, Zhirang; Zhong, Yuxia; Han, Suying; Liao, Hanwen; Duan, Yanya; Tian, Xuefei; Ren, Xiangning; Lu, Chen; Jiang, Hong

Harnessing genetically engineered cell membrane-derived vesicles as biotherapeutics

利用基因工程改造的细胞膜衍生囊泡作为生物治疗药物

Li, Xiaohong; Wei, Yuting; Zhang, Zhirang; Zhang, Xudong

In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunity

利用生物合成细菌对肿瘤进行原位免疫调节可促进抗肿瘤免疫。

Zhongda Lin ,Fanqiang Meng ,Yumeng Ma ,Chi Zhang ,Zhirang Zhang ,Zhaoxin Yang ,Yuan Li ,Linlin Hou ,Yuzhong Xu ,Xin Liang ,Xudong Zhang

Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy

了解蛋白尿肾病中足细胞的免疫反应:从发病机制到治疗

Jiang, Hong; Shen, Zhirang; Zhuang, Jing; Lu, Chen; Qu, Yue; Xu, Chengren; Yang, Shufen; Tian, Xuefei

Biosynthetic neoantigen displayed on bacteria derived vesicles elicit systemic antitumour immunity

细菌来源囊泡上展示的生物合成新抗原可诱导全身性抗肿瘤免疫。

Fanqiang Meng ,Liyan Li ,Zhirang Zhang ,Zhongda Lin ,Jinxie Zhang ,Xiao Song ,Tianyuan Xue ,Chenyang Xing ,Xin Liang ,Xudong Zhang

Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy

表达 CD64 的基因工程细胞囊泡作为癌症免疫治疗的检查点抗体载体

Liyan Li, Qianwei Miao, Fanqiang Meng, Baoqi Li, Tianyuan Xue, Tianliang Fang, Zhirang Zhang, Jinxie Zhang, Xinyu Ye, Yang Kang, Xingding Zhang, Qian Chen, Xin Liang, Hongbo Chen, Xudong Zhang